Community-based Tuberculosis Tracing and Preventive Therapy

NACompletedINTERVENTIONAL
Enrollment

1,400

Participants

Timeline

Start Date

October 14, 2019

Primary Completion Date

August 1, 2022

Study Completion Date

August 1, 2022

Conditions
Tuberculosis
Interventions
OTHER

Screening and initiating preventive therapy in communities

Symptom-based screening of tuberculosis household child contacts by community health workers; initiation of preventive therapy (3 months of a fixed-dose combination of rifampicin-isoniazid or 6 months isoniazid for HIV+ children on protease inhibitors) in the household by a nurse; follow-up of children under preventive therapy by a community health worker for eligible children at community level, and referral of presumptive tuberculosis cases (children and adults) to the facility.

Trial Locations (25)

Unknown

Hôpital de district Bonassama, Bonabéri

Hôpital de district Log-Baba, Douala

Centre Médical d'arrondissement Delangue, Edéa

Hôpital de district Mbalmayo, Mbalmayo

Hôpital de district Mfou, Mfou

Hôpital régional Nkongsamba, Nkongsamba

Hôpital de district Okola, Okola

Hôpital de district Olembe, Olembé

Hôpital de district St Jean de Malte, Penja

Hôpital de district Yoko, Yoko

Ishongororo HC IV, Ibanda

Ruhoko HC IV, Ibanda

Kabwohe Clinical Research Center HC II, Kabwohe

Kabwohe HC IV, Kabwohe

Kitagata Hospital, Kitagata

Bubaare HC III, Mbarara

Bwizibwera HC IV, Mbarara

Kakoba HC III, Mbarara

Mbarara Municipal Council HC IV, Mbarara

Bwongyera HC III, Ntungamo

Itojo Hospital, Ntungamo

Kitwe HC IV, Ntungamo

Ntungamo Ngoma HC III, Ntungamo

Rubaare HC IV, Ntungamo

Rwashamaire HC IV, Ntungamo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Epicentre

OTHER

collaborator

University of Sheffield

OTHER

collaborator

Institut de Recherche pour le Developpement

OTHER_GOV

lead

Elizabeth Glaser Pediatric AIDS Foundation

OTHER

NCT03832023 - Community-based Tuberculosis Tracing and Preventive Therapy | Biotech Hunter | Biotech Hunter